Open Calls
There are currently no open calls available.
Upcoming Calls
There is no information on upcoming calls at the moment.
Closed Calls
-
Networking Support Call (NSC) 2025
EP PerMed’s Networking Support Call 2025 (NSC2025) represents a key instrument for fostering collaboration, knowledge exchange, and community building in personalised medicine (PM) across Europe and beyond. With a total investment of €389,000, EP PerMed will fund 13 networking events with a diverse portfolio spanning multiple health categories and research domains.
-
Fast Track Validation Programme 2026
The EP PerMed Fast Track Programme 2026 offers targeted support to accelerate the validation and adoption of innovative personalised medicine solutions. The programme helps early-stage innovations progress by at least one Technology Readiness Level through dedicated validation studies carried out together with specialised European validation centres.
-
EP PerMed Joint Transnational Call (JTC) 2026
The Joint Transnational Call (JTC) 2026 “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases” (acronym: CARMEN2026), co-funded by the European Union, will fund multinational, innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe and beyond in this field.
-
Twinning Call 2026
The Twinning Call 2026 is designed to accelerate the implementation of personalised medicine (PM) solutions or approaches from one country to another through peer-to-peer exchanges. This call offers up to 50,000 EUR to activities that facilitate the exchange of solutions or approaches in personalised medicine and build up the capacities and capabilities of one or…
-
Fast Track Validation Programme – Call Announcement
The Call is closed! The EP PerMed Fast Track Call closed in June 2025. Call statistics are available here. Introduction Personalised Medicine (PM) represents a paradigm shift from a “one size fits all” approach to an optimised strategy for the prevention, diagnosis and treatment of disease for each individual, based on their unique characteristics, including…
-
Research, Innovation and Technology Call for Proposals (RITC) 2026
EP PerMed has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).
-
EP PerMed Joint Transnational Call (JTC) 2025
EP PerMed has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over 36.5 Mio. € (approx.).
-
Education Call: Guide to Personalised Medicine for Healthcare Professionals
The purpose of this call is to support the provision and development of educational content for healthcare professionals on the implementation of personalised medicine. Submission The objective of this Call is to provide subgrant funding to support the provision and development of educational content aimed at healthcare professionals (HCPs) in the implementation of personalised medicine…
-
Venture Creator
Introduction Personalised Medicine (PM) represents a paradigm shift from a “one size fits all” approach to an optimised strategy for the prevention, diagnosis and treatment of disease for each individual, based on their unique characteristics, including biological features (e.g., phenotype, endotype, genotype), as well as lifestyle and environmental factors. Accordingly, PM puts the patient at…
-
Fast Track Validation Programme 2025
Eight outstanding projects were selected for the EP PerMed Fast Track Validation Programme, an initiative designed to accelerate the development, validation, and adoption of innovative personalised medicine (PM) solutions across Europe.